Previous Next

2024-02-21

Dapagliflozin in chronic renal failure

Urology-nephrology

SGLT2 inhibitors lower blood pressure in patients with type 2 diabetes. But how much of an effect does dapagliflozin have on blood pressure in patients with chronic renal failure? A study was conducted here on 4,304 adults with kidney failure, with or without type 2 diabetes. At week 2, dapagliflozin had reduced SAP by 3.6 mmHg, compared with placebo. This effect was maintained throughout the trial, with a median follow-up of 2.4 years. The mean reduction in SBP with dapagliflozin was 3.2 mmHg in diabetic subjects and 2.3 mmHg in non-diabetic subjects.

Source(s) :
Hiddo Jl Heerspink et al. Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria. Am Heart J. 2024 Feb 15:S0002-8703(24)00033-4. ;

Last press reviews


Peanut under control?

#Immunotherapy #FoodAllergy #Peanut #Desensitization   &nbsp...

Lupus under control?

#Lupus #SLE #Baricitinib #JAK #Autoimmunity    

Sepsis & homocysteine: a biomarker under influence?

#Sepsis #Homocysteine #Biomarker #Mortality #PersonalizedMedicine #Inte...